Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on August 17, 2020. The report addresses a notification received from The Nasdaq Stock Market LLC regarding the Company's failure to meet continued listing requirements.
Key Financial Metrics
- Stockholders' Equity: $1,544,000 (as reported in the Form 10-Q for the quarter ended June 30, 2020).
- Listing Requirement Threshold: $2,500,000 minimum stockholders' equity.
- Alternative Compliance Metrics: Market value of listed securities of $35 million or net income from continuing operations (specific values not provided in this filing).
- Revenue, Profit, Cash Flow, Debt: The filing text does not provide clear values for these metrics.
Material Changes and Listing Status
The Company received a letter from the Nasdaq Listing Qualifications Staff stating it no longer complies with Nasdaq Listing Rule 5550(b)(1) due to insufficient stockholders' equity. While the stock remains listed under the symbol JAGX, the Company is in a non-compliant status and must take action to avoid delisting.
Outlook, Management Commentary, and Risks
- Compliance Plan Deadline: The Company has 45 calendar days, until October 1, 2020, to submit a plan to regain compliance.
- Extension Possibility: If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days (until February 13, 2021) to demonstrate compliance.
- Delisting Risk: If the plan is not accepted, the stock will be subject to delisting. The Company retains the right to appeal such a decision to a Nasdaq hearings panel.
- Management Intent: The Company intends to submit a compliance plan by the October 1, 2020 deadline.
- Forward-Looking Statements: There is no assurance that Nasdaq will accept the plan or that the Company will successfully regain compliance with equity, market value, or net income requirements.
Investor Verification Checklist
- Verify the Company's submission of a compliance plan to Nasdaq by October 1, 2020.
- Monitor Nasdaq's decision on the acceptance of the compliance plan.
- Review the Company's Form 10-Q for the quarter ended June 30, 2020, for detailed financial context regarding the $1,544,000 equity figure.
- Check for any subsequent filings regarding the Company's ability to raise capital or improve net income to meet alternative listing standards.